CAH Cardinal Health
Updated
S&P 500 CompaniesDividend Aristocrats
Industrials · Wholesale-Drugs, Proprietaries & Druggists' Sundries
Cardinal Health (CAH) is a industrials company in the Wholesale-Drugs, Proprietaries & Druggists' Sundries industry, with a market capitalization of $57.8 billion. Shares last traded at $248.54, 3.7% below their 52-week high. Over the past year the stock is up 65.1%. CAH trades at a price-to-earnings ratio of 34.78, above the Wholesale-Drugs, Proprietaries & Druggists' Sundries median of 23.95. Net profit margin is 0.7%, below the peer median of 0.7%. Revenue grew 14.2% year over year. The shares yield 0.8% in dividends.
Performance
Chart
Full chart →Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.
Technicals
Financials
Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.
CAH Dividend History
| Fiscal year end | Total dividends paid | Per share* | Payout ratio |
|---|---|---|---|
| 2026-06-30 | $491M | $2.07 | 29% |
| 2025-06-30 | $494M | $2.04 | 32% |
| 2024-06-30 | $499M | $2.02 | 59% |
| 2023-06-30 | $525M | $2.00 | 159% |
| 2022-06-30 | $559M | $2.00 | — |
| 2021-06-30 | $573M | $1.95 | 94% |
| 2020-06-30 | $569M | $1.94 | — |
| 2019-06-30 | $577M | $1.92 | 42% |
| 2018-06-30 | $581M | $1.84 | 227% |
| 2017-06-30 | $577M | $1.80 | 45% |
| 2016-06-30 | $512M | $1.55 | 36% |
| 2015-06-30 | $460M | $1.37 | 38% |
*Per share derived as total dividends paid ÷ weighted diluted shares (SEC EDGAR/XBRL annual cash-flow facts). Reported history — not a forecast of future dividends.
CAH is a Dividend Aristocrat (25+ consecutive years of increases). Compare payers on the highest-dividend-yield screener.
Recent earnings
| Period | EPS (diluted) | Reported |
|---|---|---|
| FY 2026 | $7.23 | 2026-08-11 |
| Q1 2026 | $1.88 | 2025-10-30 |
| FY 2026 | $6.45 | 2026-08-11 |
| Q1 2026 | $1.70 | 2025-10-30 |
| FY 2026 | $3.45 | 2026-08-11 |
| FY 2024 | $1.07 | 2024-08-14 |
Wholesale-Drugs, Proprietaries & Druggists' Sundries peers
CAH vs 9 industry peers (Wholesale-Drugs, Proprietaries & Druggists' Sundries), by market cap. Updated
| MCK | McKesson Corporation | $107.4B | 23.39 | 0.26 | 1.1% | -0.40% |
| COR | Cencora | $64.3B | 24.51 | 0.19 | 0.8% | +0.23% |
| CAH | Cardinal Health | $57.8B | 34.78 | 0.24 | 0.7% | +1.24% |
| HLF | Herbalife Ltd. | $1.3B | 7.76 | 0.25 | 3.2% | -0.08% |
| NUS | NU SKIN ENTERPRISES, INC. | $228M | -1.05 | 0.17 | -15.7% | -2.90% |
| COSM | Cosmos Health Inc. | $27M | -1.10 | 0.37 | -33.1% | +18.78% |
| HWH | HWH International Inc. | $15M | -5.54 | — | — | +2.98% |
| MEDS | DataMeds AI, Inc. | $3M | -0.03 | — | — | -4.49% |
| HKPD | Cellyan Biotechnology Co., Ltd | — | — | — | — | -7.89% |
Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.